All Episodes
|
141
|
Robin Shah

Podcast 141: Oncology Super-Networks, Payers, And Their Impact On Patient Care with Robin Shah

Mar 25, 2022

Episode Summary

We took a long break — we've been busy at Darwin — but we’re back with a great lineup of guests for Season 6! We kick off this season with Robin Shah, Founder and CEO of Thyme Care and founding member of OneOncology. John and Robin discuss the classification of super-networks and break down the differences in existing models. Find out how payers are managing various disease states by outsourcing their risk and the impact it has on patient care. Please rate and review if you like Health Care Rounds as it helps other people find us!

Episode Notes

Robin Shah is the Founder and CEO of Thyme Care, an oncology care management solution providing high-touch, tech-enabled cancer care navigation. Thyme Care was founded with the mission to radically improve the journey for every person diagnosed with cancer.  At the heart of it all is the belief that providing patients with access to the right team at the right time will lead to better quality, outcomes, costs, and ultimately patient experience.

Before launching Thyme Care, Robin was a founding member of OneOncology, where he served as the Chief Development and Marketing Officer. Robin’s passion for building a stronger future for community oncology then brought him to Flatiron Health, a leading healthcare technology company. There, Robin served as Vice President of Provider Marketing and Strategy. Robin also helped manage a comprehensive community cancer center in his hometown, Gettysburg, PA.

Robin earned his bachelor’s degree in biomedical engineering from George Washington University and holds an M.B.A from the Carey Business School at Johns Hopkins University.

John Marchica, CEO, Darwin Research Group

John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.

John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 200: How Health Systems Build Elite Clinical Leaders w/ Dr. Jonathan Stallkamp, CMO, Main Line Health
Podcast 199: A New Blueprint for Rural Health Care w/ Natalie L. Baggio, President, Corewell Health South
Podcast 198: Standing Strong as an Independent Health System w/ Dr. Allen Smith & Dr. Sam Ash, South Shore Health
Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD

Recommended Content

Browse Library
INsights
February 16, 2026

Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes

Read More
INsights
February 9, 2026

Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports

Read More
INsights
February 2, 2026

Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.